Diceros Therapeutics, Inc.

Biotechnology company · Newton, Massachusetts, United States

Diceros Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Diceros Therapeutics at a glance

Typebiotechnology company

HeadquartersNewton, Massachusetts, United States

Earliest incorporation on record2022

SEC CIK1948469

What does Diceros Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $12.6 million sold (2024).

Frequently asked questions about Diceros Therapeutics

Where is Diceros Therapeutics headquartered?

Diceros Therapeutics, Inc. is headquartered in Newton, Massachusetts, United States.

What does Diceros Therapeutics do?

Diceros Therapeutics, Inc. is a biotechnology company.

When was Diceros Therapeutics founded?

The earliest incorporation on record for Diceros Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Lumicell, Inc.Newton, Massachusetts, United States
Acumen Pharmaceuticals, Inc.Newton, Massachusetts, United States
Courage Therapeutics, Inc.Newton, Massachusetts, United States
Extend Biosciences IncNewton, Massachusetts, United States
Normatec Industries, LPNewton, Massachusetts, United States
TheraNano LLCNewton, Massachusetts, United States
Auron Therapeutics, Inc.Newton, Massachusetts, United States
Inflammasome Therapeutics, Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences